Bluejay expands SanyoSeiko partnership for Symphony platform commercialization

Bluejay Diagnostics, Inc.

SanyoSeiko will serve as contract manufacturing organization for analyzers, cartridges, and components.
SanyoSeiko to oversee fulfillment, kit assembly, labeling, packaging, shipping, and quality control.
Partnership includes manufacturing redevelopment, raw material sourcing, vendor compliance, and regulatory support.
Bluejay's Symphony platform is a near-patient testing system for biomarkers like IL-6 in sepsis management.
No financial terms disclosed; Symphony not yet FDA cleared.

item 1.01item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.